News

Boussard & Gavaudan's Latest NAV Insights for Investors

Boussard & Gavaudan's Latest NAV Insights for Investors

Boussard & Gavaudan Holdings Overview

Boussard & Gavaudan Holding Limited is a closed-ended investment company based in Guernsey that primarily focuses on alternative investment strategies. The company aims to provide its shareholders with substantial returns through its various investment avenues. The latest updates regarding the company's net asset value (NAV) have just been announced, providing critical insights for both current and prospective investors.

Recent NAV Announcement

The management of Boussard & Gavaudan has released the estimated NAV for its ordinary shares as of the close of business on October 10. It reflects the company's performance over the recent period. For Euro shares, the estimated NAV stands at €28.3593, while the Sterling shares have an estimated NAV of £25.5021. It's noteworthy that these values are calculated net of management and performance fees.

Monthly and Yearly Returns

Investors looking to track the performance of their investments can observe the estimated month-to-date return for the Euro shares is at 0.00%, and for the Sterling shares, it slightly stands at 0.03%. Year-to-date, the performance has been 2.94% for Euro shares and 3.79% for Sterling shares. Meanwhile, since inception, the returns have been impressive, with Euro shares showing an estimated ITD return of 183.59% and Sterling shares at 155.02%.

Market Information Overview

Boussard & Gavaudan Holdings’ shares are actively traded, and investors should stay informed about the latest market prices. As per the most recent market data, the closing price for the Euro shares on the Amsterdam Exchange was €27.20. This reflects a premium/discount of -4.09% related to the estimated NAV. Unfortunately, the London Stock Exchange listing does not currently show available price data, reflecting a common occurrence in dynamic markets.

Transactions and Treasury Insights

Regarding the transactions involving the company’s own securities, there have been no publicly reported transactions as these shares remain under treasury. For investors interested in the liquidity enhancement agreement, these typically involve strategies to maintain stability within the trading environment. The average price and number of shares for this initiative remain unspecified.

Share Capital Breakdown

Boussard & Gavaudan also reported on its ordinary shares capital structure. Notably, there are 12,299,516 Euro shares outstanding and 123,090 Sterling shares. The information serves as a crucial indicator for investors assessing the company's equity distribution and market positioning.

BG Fund NAV Insights

Additionally, the estimated NAV for the BG Fund indicates that Class B Euro Shares hold an estimated NAV of €256.4116, while Class GBP A Shares show an estimated NAV of £136.6359. These particular share classes demonstrate the investment opportunities that BG Fund offers, emphasizing a fee structure that does not impose additional manager fees on Class B Euro Shares.

Company Overview

The Boussard & Gavaudan entity has established itself firmly as a reputable name in alternative investment strategies. With the necessary approvals from the Guernsey Financial Services Commission and registrations in the Dutch Authority for Financial Markets, their shares are listed on Euronext Amsterdam, providing broad access to interested investors. This positioning is designed to cater to both local and international markets, enhancing overall investment potential.

If you wish to know more about Boussard & Gavaudan Holdings or require assistance, feel free to reach out directly to their contact person:

Boussard & Gavaudan Investment Management, LLP.
Emmanuelle Gavaudan
+44 (0) 20 3751 5389
Email: info@bgam-uk.com

Frequently Asked Questions

What is the latest NAV for Boussard & Gavaudan?

The latest estimated NAV is €28.3593 for Euro shares and £25.5021 for Sterling shares.

How has the company's performance been this year?

Year-to-date returns indicate a performance of 2.94% for Euro shares and 3.79% for Sterling shares.

Where are Boussard & Gavaudan shares listed?

The shares are listed on Euronext Amsterdam and the London Stock Exchange.

Are any treasury shares currently in circulation?

There have been no reported transactions of shares purchased into treasury.

Who can I contact for more information?

You can reach Emmanuel Gavaudan at Boussard & Gavaudan Investment Management for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 85

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China

Updated Category News Views 135

Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...

Continue Reading
Eunice Goldstein Winery's Luxe Holiday Gifting Revolution

Updated Category News Views 15

Shaking Up the Holiday Gifting Game You ever feel like holiday gifting is stuck in a rut? Same old generic bottles and baskets. But, here comes Eunice Chiweshe Goldstein Winery, charging in with a fresh take on holiday generosity. This ain't just about selling wine—this is about crafting an experience for both giver and receiver. Perfect for those looking to ditch the...

Continue Reading
Tokenized Securities: Transfer Online's Next Frontier

Updated Category News Views 68

Transfer Online Teams Up with OnchainTA Hold onto your investment hats, folks—Transfer Online is linking arms with OnchainTA to step right into the future playground of tokenized securities. Now, what's that mean? Well, it's like jumping from sailing schooners to speedboats; we're entering a whole new era in capital markets. What's At Stake? The pair-up between these...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 442

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Laser Weapon Market to Double: Military Demand Surges

Updated Category News Views 96

Pew Pew: Lasers Are the Future of Defense Forget lightsabers, we've got something even flashier—a market that's going to double in worth by 2035. High-energy laser weapons are coming in hot, growing from USD 2.17 billion in 2026 to an estimated USD 4.54 billion by the end of 2035. That's no small potatoes! What's Driving This Beam Dream? The military is all about upping...

Continue Reading
Crude Insight: Refining Margins Expand, LNG Orders Rise

Updated Category News Views 51

Refining Margins Stretch While LNG Orders Surge Well, folks, oil markets have sure been a rollercoaster lately. WTI futures danced all over the place, closing near $96 a barrel after brushing against both $93 and $99 earlier this week. Brent wasn't left out of the tango, setting at $103.60. Everyone's holding their breath each time these numbers come through. Energy...

Continue Reading
CALLAHEAD Unveils AQUA MOVER: Revolutionizing Freshwater Tanks

Updated Category News Views 20

CALLAHEAD: Bringing Storms to Water Tanks Fresh to the party in the portable sanitation sector is the AQUA MOVER™ from CALLAHEAD. Now, this ain't your everyday contraption. Charles W. Howard, the mastermind and big cheese behind CALLAHEAD, has rolled out what seems like a microscopic hurricane for water tanks—a solution to tackle the old enemy: stagnation. What Makes...

Continue Reading
Tigo Energy Faces Legal Heat Over Fraud Allegations

Updated Category News Views 123

Tigo Energy's Legal Battle Heats Up If you haven't been paying attention, it’s time to get your eyes on Tigo Energy (NASDAQ: TYGO). The company is now in the hot seat with a securities fraud lawsuit that's got investors on edge. This isn’t just a minor squabble; we're talking about allegations that could shake the ground beneath its share price. The Claims and...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 100

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading

Top 5 Most Recently Viewed Articles

Western Metallica Secures Funding for Next Exploration Phase

Updated Category News Views 124

Western Metallica Secures Bridge Financing Western Metallica Resources Corp. (TSXV: WMS) is making strides in its operational capabilities by securing bridge financing of CDN$100,000. This financing is crucial as it will support the company’s ongoing exploration activities at the Luz Maria copper-molybdenum target, part of the esteemed Caña Brava Project. Details of...

Continue Reading
Middlefield Canadian Income PCC Announces Transition to New Fund Model

Updated Category News Views 174

Middlefield Canadian Income PCC Announces Transition to New Fund Model Middlefield Canadian Income PCC (the “Company”) is making significant moves to innovate its investment structure. This announcement highlights the results of recent shareholder elections regarding the future of the Middlefield Canadian Income – GBP PC (the “Fund”). The Board has presented an...

Continue Reading
Victory Tire & Auto Strengthens Position with New Acquisition

Updated Category News Views 150

Victory Tire & Auto Expands Its Reach with New Acquisition Victory Tire & Auto, a trusted name in the automotive repair industry since 1997, has made significant strides in expanding its operations with the acquisition of Babcock Auto Care. This strategic move represents the company's 24th location in Minnesota, further solidifying its commitment to providing top-notch...

Continue Reading
Flowcore's Rebranding: A New Era in Water Solutions

Updated Category News Views 191

Flowcore's Exciting Transformation Flowcore, previously known as Priceless Water Wells, is embarking on a significant rebranding journey. This change underscores the company's growth and its expanded portfolio of water services available to the community. Why the Name Change? The decision to adopt the name Flowcore aligns closely with the company’s mission to embody the...

Continue Reading
iTeos Therapeutics to Engage Investors in Upcoming Conferences

Updated Category News Views 79

iTeos Therapeutics to Connect with Investors at Upcoming Conferences iTeos Therapeutics, Inc. (NASDAQ: ITOS), a clinical-stage biopharmaceutical company recognized for its innovative work in immuno-oncology, has announced its involvement in two significant investor conferences scheduled for September. Conference Participation Details The management team of iTeos will be...

Continue Reading